We are pleased to have reached an important milestone in our clinical trial: the first patient has been enrolled in EMPASTONE at the study site in Bern, Switzerland!
We look forward to recruiting many more patients in the coming months. Our goal is to enrol a total of 400 participants in EMPASTONE.